Iida, Shinsuke
Ichinohe, Tatsuo
Shinagawa, Atsushi
Suzuki, Kenshi
Takezako, Naoki
Aoki, Masayuki
Clinical trials referenced in this document:
Documents that mention this clinical trial
Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma
https://doi.org/10.1007/s12185-017-2390-2
Funding for this research was provided by:
This study was sponsored by Janssen Research & Development, LLC
Article History
Received: 31 August 2017
Revised: 7 December 2017
Accepted: 7 December 2017
First Online: 19 December 2017